Literature DB >> 17252604

Cells meeting our immunophenotypic criteria of endothelial cells are large platelets.

Michiel H Strijbos1, Jaco Kraan, Michael A den Bakker, Bart N Lambrecht, Stefan Sleijfer, Jan W Gratama.   

Abstract

BACKGROUND: Circulating endothelial cells (CEC) are shed from damaged vasculature, making them a rational choice to serve as surrogate marker for vascular damage. Currently, various techniques and CEC definitions are in use, and their standardization and validation is needed. A flow cytometric single platform assay defining CEC as forward light scatter (FSC)(low-to-intermedate), sideward light scatter (SSC)(low), CD45(-), CD31(++) and CD146(+) is a promising approach to enumerate CEC because of its simplicity (Mancuso et al., Blood 2001;97:3658-3661). Here, we set out to confirm the endothelial nature of these cells.
METHODS: We isolated cells with a FSC(low-to-intermediate), SSC(low), CD31(++), CD45(dim) immunophenotype (termed "cells meeting our immunophenotypic criteria for endothelial cells" [CMOIC]) from healthy donors to study the expression of endothelium-associated markers using several techniques. Special attention was paid to reagents identifying the endothelial cell-specific marker CD146. We compared antigen expression patterns of CMOIC with those of the HUVEC endothelial cell line and lymphocytes. Electron microscopy was used to detect the presence of endothelial cell-specific Weibel-Palade bodies in the sorted cells.
RESULTS: CD146 expression was negative on CMOIC for all tested CD146 mAbs, but positive on HUVEC cells and a minor subset of T lymphocytes. Using flow cytometry, we found no expression of any endothelium-associated marker except for CD31 and CD34. HUVEC cells were positive for all endothelial markers except for CD34. Evaluation of CMOIC morphology showed a homogenous population of cells with a highly irregular nucleus-like structure and positive endothelial immunohistochemistry. CMOIC contained neither nuclei nor DNA. Electron microscopy revealed the absence of a nucleus, the absence of endothelial specific Weibel-Palade bodies, and revealed CMOIC to be large platelets.
CONCLUSION: The vast majority of cells with the immunophenotype FSC(low-to-intermediate), SSC(low), CD45(-), CD31(++) do not express CD146 and are large platelets rather than endothelial cells. (c) 2007 Clinical Cytometry Society.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17252604     DOI: 10.1002/cyto.b.20156

Source DB:  PubMed          Journal:  Cytometry B Clin Cytom        ISSN: 1552-4949            Impact factor:   3.058


  15 in total

1.  Flow cytometric identification and functional characterization of immature and mature circulating endothelial cells.

Authors:  Julie A Mund; Myka L Estes; Mervin C Yoder; David A Ingram; Jamie Case
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-01-26       Impact factor: 8.311

2.  Discrimination between circulating endothelial cells and blood cell populations with overlapping phenotype reveals distinct regulation and predictive potential in cancer therapy.

Authors:  Patrick Starlinger; Philipp Brugger; Christian Reiter; Dominic Schauer; Silvia Sommerfeldt; Dietmar Tamandl; Irene Kuehrer; Sebastian F Schoppmann; Michael Gnant; Christine Brostjan
Journal:  Neoplasia       Date:  2011-10       Impact factor: 5.715

3.  Isolation of a circulating CD45-, CD34dim cell population and validation of their endothelial phenotype.

Authors:  Margaret M Tropea; Bonnie J A Harper; Grace M Graninger; Terry M Phillips; Gabriela Ferreyra; Howard S Mostowski; Robert L Danner; Anthony F Suffredini; Michael A Solomon
Journal:  Thromb Haemost       Date:  2014-07-24       Impact factor: 5.249

4.  Coronary artery endothelial cells and microparticles increase expression of VCAM-1 in myocardial infarction.

Authors:  Christopher E Radecke; Alexandra E Warrick; Gagan D Singh; Jason H Rogers; Scott I Simon; Ehrin J Armstrong
Journal:  Thromb Haemost       Date:  2014-11-20       Impact factor: 5.249

5.  Levels of a subpopulation of platelets, but not circulating endothelial cells, predict early treatment failure in prostate cancer patients after prostatectomy.

Authors:  C K E Wong; B Namdarian; J Chua; X Chin; R Speirs; T Nguyen; M Fankhauser; J Pedersen; A J Costello; N M Corcoran; C M Hovens
Journal:  Br J Cancer       Date:  2012-10-09       Impact factor: 7.640

6.  In vitro characterization of circulating endothelial progenitor cells isolated from patients with acute coronary syndrome.

Authors:  Diana Campioni; Giorgio Zauli; Stefania Gambetti; Gianluca Campo; Antonio Cuneo; Roberto Ferrari; Paola Secchiero
Journal:  PLoS One       Date:  2013-02-11       Impact factor: 3.240

7.  Quantification of circulating endothelial and progenitor cells: comparison of quantitative PCR and four-channel flow cytometry.

Authors:  Michael Steurer; Johann Kern; Matthias Zitt; Albert Amberger; Monika Bauer; Günther Gastl; Gerold Untergasser; Eberhard Gunsilius
Journal:  BMC Res Notes       Date:  2008-08-28

Review 8.  Circulating endothelial cells in oncology: pitfalls and promises.

Authors:  M H Strijbos; J W Gratama; J Kraan; C H Lamers; M A den Bakker; S Sleijfer
Journal:  Br J Cancer       Date:  2008-05-27       Impact factor: 7.640

Review 9.  Endothelial progenitor cells: identity defined?

Authors:  Frank Timmermans; Jean Plum; Mervin C Yöder; David A Ingram; Bart Vandekerckhove; Jamie Case
Journal:  J Cell Mol Med       Date:  2009-01       Impact factor: 5.310

10.  Biological effects of anti-CD34-coated ePTFE vascular grafts. Early in vivo experimental results.

Authors:  Wojciech Mrówczyński; Alessio Rungatscher; Franz Buchegger; Jean-Christophe Tille; Sophie Namy; Osman Ratib; Michael Kutryk; Beat Hans Walpoth
Journal:  Kardiochir Torakochirurgia Pol       Date:  2014-06-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.